VXRT Stock – What Will Vaxart, Inc. (NASDAQ:VXRT) Be Like After It Drops -338.38% From Its Highs?

During the recent session, Vaxart, Inc. (NASDAQ:VXRT)’s traded shares were 1,185,822, with the beta value of the company hitting 0.03. At the last check, the stock’s price was $5.68, reflecting an intraday loss of -0.18% or -$0.01. The 52-week high for the VXRT share is $24.9, that puts it down -338.38% from that peak though still a striking +71.48% gain since the share price plummeted to a 52-week low of $1.62. The company’s market capitalization is $678.21 Million, and the average intraday trading volume over the past 10 days was 2.94 Million shares, and the average trade volume was 14.58 Million shares over the past three months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Vaxart, Inc. (VXRT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2. VXRT has a Sell rating from none of the analyst(s) out of 2 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 2 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.1.

Vaxart, Inc. (VXRT) registered a -0.18% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 10.44% in intraday trading to $6.32- this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is -6.45%, and it has moved by -6.21% in 30 days. Despite these dips, the overall price performance for the year is -0.88%. The short interest in Vaxart, Inc. (NASDAQ:VXRT) is 25.8 Million shares and it means that shorts have 1.77 day(s) to cover.

The consensus price target of analysts on Wall Street is $11.5, which implies an increase of 102.46% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $13 respectively. As a result, VXRT is trading at a discount of 128.87% off the target high and 76.06% off the low.

Vaxart, Inc. (VXRT) projections and forecasts

Statistics show that Vaxart, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Vaxart, Inc. (VXRT) shares have jump down -18.77% during the last six months, with a year-to-date growth rate more than the industry average at 86.11% against 16.9%. Yet analysts are winding down their growth forecast for the fiscal year 2021. Revenue is predicted to decline -400% this quarter and then jump 8.3% in the quarter after that. In the rating firms’ projections, revenue will increase 551.3% compared to the previous financial year.

Revenue for the current quarter is expected to be $620Million as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to $750Million by the end of June 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarter totaled $2.8 Million. In this case, analysts expect current quarter sales to lessen by -77.9%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 45%. While earnings are projected to return 57.8% in 2021, the next five years will return 0% per annum.

Vaxart, Inc. (NASDAQ:VXRT)’s Biggest Investors

Vaxart, Inc. insiders own 0.6% of total outstanding shares while institutional holders control 34.39%, with the float percentage being 34.6%. State Street Corporation is the largest shareholder of the company, while 193 institutions own stock in it. As of Dec 30, 2020, the company held over 9.44 Million shares (or 8.02% of all shares), a total value of $53.93 Million in shares.

The next largest institutional holding, with 5.16 Million shares, is of Vanguard Group, Inc. (The)’s that is approximately 4.38% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $29.48 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Also, the Mutual Funds coming in first place with the largest holdings of Vaxart, Inc. (VXRT) shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. Data provided on Feb 27, 2021 indicates that SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF owns about 8,874,104 shares. This amounts to just over 7.54 percent of the company’s overall shares, with a $63.45 Million market value. The same data shows that the other fund manager holds slightly less at 2.95 Million, or about 2.51% of the stock, which is worth about $16.87 Million.